|
مقاله
|
Abstract
|
|
|
Title:
|
106Ruthenium Plaque Therapy (RPT) for Retinoblastoma
|
Author(s):
|
Naseripoor Masoud,Astaraki Arezoo, Eshaghi Acieh,Sedaghat Ahad
|
Presentation Type:
|
Poster
|
Subject:
|
Posterior Segment and Uveitis
|
Others:
|
|
Presenting Author:
|
|
Name:
|
Arezoo Astaraki
|
Affiliation :(optional)
|
Rasoul Akram Hospital,Eye research center
|
E mail:
|
dr.astaraki@gmail.com
|
Phone:
|
22676658
|
Mobile:
|
09122008967
|
|
|
Purpose:
|
To evaluate the efficacy of Ru plaque brachytherapy for the treatment of retinoblastoma.
|
Methods:
|
We reviewed a retrospective, noncomparative case series of 28 children with retinoblastoma treated with Ru-plaques at Rsoul Akram Hospital between 2003 and 2012, with average 66.7 ± 23 months of follow-up.
|
Results:
|
A total of 33 tumors were treated with Ru brachytherapy in 33 eyes. The average patient age was27.4 ± 22 months. Ru brachytherapy was the first-line treatment for 2 tumors (6.1%), second-line treatment for14(42.4%)tumors, and salvage treatment for 17 (51.5%%) tumors resistant to
other treatment modalities..Eye retention was achieved in 54.5% of cases (18 of33 eyes).Radiation complications included mild vitreous haemorrhage in 3(9.1%),maculopathy in 2(6.1%), and subcap-sular cataract in 2(6.1%) of 33 eyes.
|
Conclusion:
|
RU brachytherapy is an effective treatment for retinoblastoma,with few secondary complications.
|
Attachment:
|
7002.pptx
|
|